AntiviralGeneral AntiviralPositive observation
Record detail Table 1: A45-LDL EC50/IC50 0.6 ± 0.1 µM (EMSA).
- Measure
- EC50
- Value
- 0.6 ± 0.1 µM (EMSA)
- Target
- SARS-CoV-2
- Assay
- Not reported by source
Back to Evidence
Paper-scoped peptide mentionSequence not reported or unresolved
A45-LDL
PMC10668963::PEP000002
Source publication
Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication
Biomolecules · 2023
- Sequence status
- not reported or unresolved
- Standardization
- Sequence unresolved
- Source location
- unknown
- Activity records
- 1
Sequence evidence
Reported molecular identity
The publication reports a peptide label or compound identity, but no sequence could be safely standardized from the available text, table, figure, or structure context.
Table 1: A45-LDL EC50/IC50 0.6 ± 0.1 µM (EMSA).
Experimental observations
Records linked to this mention
Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.